Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
CC transcript
10-Q late filing
Inv. presentation
Director departure
WELLCARE HEALTH PLANS, INC. (WCG) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/23/2020 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Amended and Restated Certificate of Incorporation of WellCare Health Plans, Inc",
"Amended and Restated Bylaws of WellCare Health Plans, Inc"
12/17/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/30/2019 8-K Quarterly results
07/30/2019 8-K Quarterly results
06/24/2019 8-K Quarterly results
06/14/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 14, 2019 WELLCARE HEALTH PLANS, INC. Delaware 001-32209 47-0937650 8735 Henderson Road, Renaissance One Tampa, Florida 33634 Registrant's telephone number, including area code: 290-6200 Not Applicable. Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act..."
05/23/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/30/2019 8-K Quarterly results
Docs: "WELLCARE REPORTS FIRST QUARTER 2019 RESULTS"
03/27/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Agreement and Plan of Merger, by and among Centene Corporation, WellCare Health Plans, Inc., Wellington Merger Sub I, Inc. and Wellington Merger Sub II, Inc",
"Centene and WellCare to Combine to Create a Premier Healthcare Enterprise Focused on Government-Sponsored Healthcare Programs"
02/25/2019 8-K Quarterly results
02/05/2019 8-K Quarterly results
01/07/2019 8-K Investor presentation
Docs: "PRESENTATION DATED JANUARY 7, 2019"
12/17/2018 8-K Investor presentation
Docs: "WELLCARE ISSUES 2019 ANNUAL GUIDANCE COMPANY REAFFIRMS 2018 ANNUAL GUIDANCE TAMPA, Fla. – WellCare Health Plans, Inc. today issued full-year 2019 guidance and reaffirmed its full-year 2018 guidance. For the full-year 2019, the company expects its adjusted earnings per diluted share to be in the range of $13.15 to $13.40. For the full-year 2018, WellCare continues to expect its adjusted EPS to be in a range of $10.90 to $11.00. Refer to the Appendix included in this news release for specific 2019 and 2018 guidance metrics, related footnotes and basis of presentation. In addition to the information in this release, a presentation describing the highlights of WellCare’s full-year 2019 guidance can be accessed via the following link: http://ir.wellcare.com/presentations. Full-Year 2019 Guidan...",
"PRESENTATION DATED DECEMBER 17, 2018"
10/30/2018 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Plante & Moran, PLLC, independent auditor to Caidan Enterprises, Inc",
"Unaudited consolidated financial statements and related notes of Caidan Enterprises, Inc. as of and for the six months ended June 30, 2018 and 2017",
"Unaudited pro forma condensed combined financial statements and related notes of the Company, giving effect to the Transaction for the year ended December 31, 2017 and as of and for the six months ended June 30, 2018"
10/30/2018 8-K Quarterly results
Docs: "WELLCARE REPORTS THIRD QUARTER 2018 RESULTS Company Increases Full-Year 2018 Guidance"
09/27/2018 8-K Quarterly results
09/24/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "WellCare Elects Former Louisiana Governor Bobby Jindal to Board of Directors"
09/13/2018 8-K Regulation FD Disclosure
09/04/2018 8-K Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "WELLCARE COMPLETES ACQUISITION OF MERIDIAN"
08/14/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "INDENTURE DATED AUGUST 13, 2018",
"WellCare Announces Closing of $750 Million of Senior Notes"
08/13/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "WellCare Announces Closing of Common Stock Offering"
08/08/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "WellCare Announces Pricing of $750 Million of Senior Notes"
08/08/2018 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and among the Company and SunTrust Robinson Humphrey, Inc. and J.P. Morgan Securities LLC, acting as representatives of the several underwriters named therein",
"Opinion of Kirkland & Ellis LLP",
"WellCare Announces Pricing of Common Stock"
08/06/2018 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Consent of Plante Moran, PLLC, independent registered public accounting firm to Caidan Enterprises, Inc",
"WellCare Announces Offering of $700 Million Senior Notes",
"WellCare Announces Offering of Common Stock",
"Investor Presentation",
"The historical audited consolidated financial statements and related notes of the Seller as of and for the years ended December 31, 2017 and 2016",
"The historical unaudited condensed consolidated financial statements and related notes of the Seller as of and for the three months ended March 31, 2018 and 2017",
"Unaudited pro forma condensed combined financial statements and related notes of the Company, giving effect to the Transaction, as of and for the three and twelve months ended March 31, 2018 and for the year ended December 31, 2017"
07/31/2018 8-K Quarterly results
Docs: "WELLCARE REPORTS SECOND QUARTER 2018 RESULTS Company Increases Full-Year 2018 Guidance"
07/24/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amended and Restated Credit Agreement, by and among WellCare Health Plans, Inc., JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto",
"WellCare Announces Five-Year $1.3 Billion Amended and Restated Credit Agreement"
05/29/2018 8-K Investor presentation
Docs: "WELLCARE TO ACQUIRE MERIDIAN FOR $2.5 BILLION Grows and Strengthens Medicaid and Medicare Advantage Businesses Enhances Business with Pharmacy Benefit Manager Platform Delivers Significant Revenue Growth Transaction Expected to be Accretive to Earnings Company to Host Conference Call and Webcast at 5:00 p.m. EDT Today",
"PRESENTATION DATED MAY 29, 2018"
05/24/2018 8-K Submission of Matters to a Vote of Security Holders
05/01/2018 8-K Quarterly results
Docs: "WELLCARE REPORTS FIRST QUARTER 2018 RESULTS Company Increases Full-Year 2018 Guidance"
02/06/2018 8-K Quarterly results
Docs: "WELLCARE REPORTS FOURTH QUARTER AND FULL-YEAR 2017 RESULTS Company Increases Full-Year 2018 Guidance"
01/09/2018 8-K Quarterly results
12/18/2017 8-K Investor presentation
Docs: "WellCare Issues 2018 Annual Guidance Reaffirms 2017 Annual Guidance TAMPA, Fla. – WellCare Health Plans, Inc. today issued full-year 2018 guidance and reaffirmed its full-year 2017 guidance. For the full-year 2018, the company expects its adjusted earnings per diluted share to be in the range of $8.40 to $8.65. For the full-year 2017, WellCare continues to expect its adjusted EPS to be in a range of $8.25 to $8.40. Refer to the Appendix included in this news release for specific 2018 and 2017 guidance metrics, related footnotes and basis of presentation. In addition to the information in this release, a presentation describing the highlights of WellCare’s full-year 2018 guidance can be accessed via the following link: http://ir.wellcare.com/presentations. Full-Year 2018 Guidance Highlights...",
"PRESENTATION DATED DECEMBER 18, 2017"
10/31/2017 8-K Quarterly results
10/02/2017 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy